Toxicological Evaluation of SiO₂ Nanoparticles by Zebrafish Embryo Toxicity Test.
Animals
Chorion
/ metabolism
Embryo, Nonmammalian
/ anatomy & histology
Gene Expression Regulation, Developmental
/ drug effects
Nanoparticles
/ toxicity
Neovascularization, Physiologic
/ drug effects
Protective Agents
/ metabolism
Receptors, Vascular Endothelial Growth Factor
/ genetics
Silicon Dioxide
/ toxicity
Survival Analysis
Suspensions
Toxicity Tests
Vascular Endothelial Growth Factor A
/ genetics
Zebrafish
/ embryology
bio-distribution
dechorionation
embryo acute toxicity test
silica nanoparticles
surface functionalization
vascularization
zebrafish
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Feb 2019
18 Feb 2019
Historique:
received:
30
12
2018
revised:
03
02
2019
accepted:
10
02
2019
entrez:
21
2
2019
pubmed:
20
2
2019
medline:
1
6
2019
Statut:
epublish
Résumé
As the use of nanoparticles (NPs) is increasing, the potential toxicity and behavior of NPs in living systems need to be better understood. Our goal was to evaluate the developmental toxicity and bio-distribution of two different sizes of fluorescently-labeled SiO₂ NPs, 25 and 115 nm, with neutral surface charge or with different surface functionalization, rendering them positively or negatively charged, in order to predict the effect of NPs in humans. We performed a zebrafish embryo toxicity test (ZFET) by exposing the embryos to SiO₂ NPs starting from six hours post fertilization (hpf). Survival rate, hatching time, and gross morphological changes were assessed at 12, 24, 36, 48, 60, and 72 hpf. We evaluated the effect of NPs on angiogenesis by counting the number of sub-intestinal vessels between the second and seventh intersegmental vessels and gene expression analysis of vascular endothelial growth factor (VEGF) and VEGF receptors at 72 hpf. SiO₂ NPs did not show any adverse effects on survival rate, hatching time, gross morphology, or physiological angiogenesis. We found that SiO₂ NPs were trapped by the chorion up until to the hatching stage. After chemical removal of the chorion (dechorionation), positively surface-charged SiO₂ NPs (25 nm) significantly reduced the survival rate of the fish compared to the control group. These results indicate that zebrafish chorion acts as a physical barrier against SiO₂ NPs, and removing the chorions in ZFET might be necessary for evaluation of toxicity of NPs.
Identifiants
pubmed: 30781642
pii: ijms20040882
doi: 10.3390/ijms20040882
pmc: PMC6413002
pii:
doi:
Substances chimiques
Protective Agents
0
Suspensions
0
Vascular Endothelial Growth Factor A
0
Silicon Dioxide
7631-86-9
Receptors, Vascular Endothelial Growth Factor
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Japan Society for the Promotion of Science
ID : Z9013040, JP17K08590
Références
Development. 1999 Sep;126(17):3757-67
pubmed: 10433906
Dev Biol. 2002 Aug 15;248(2):307-18
pubmed: 12167406
Am J Epidemiol. 2002 Oct 15;156(8):738-46
pubmed: 12370162
Occup Environ Med. 2003 Apr;60(4):237-43
pubmed: 12660371
Occup Med (Lond). 2004 Aug;54(5):304-10
pubmed: 15289586
Toxicol Sci. 2005 Jul;86(1):6-19
pubmed: 15703261
Part Fibre Toxicol. 2005 Oct 06;2:8
pubmed: 16209704
Biomaterials. 2007 Jul;28(19):2959-66
pubmed: 17397919
ACS Nano. 2007 Sep;1(2):133-43
pubmed: 19122772
Aquat Toxicol. 2010 Oct 15;100(2):218-28
pubmed: 20303188
Part Fibre Toxicol. 2010 Dec 03;7(1):39
pubmed: 21126379
Chem Commun (Camb). 2011 Mar 28;47(12):3442-4
pubmed: 21301716
PLoS One. 2012;7(12):e52549
pubmed: 23300705
PLoS One. 2013 Sep 18;8(9):e74606
pubmed: 24058598
Sci Rep. 2014 Jan 22;4:3810
pubmed: 24448416
Aquat Toxicol. 2014 May;150:189-200
pubmed: 24685623
Regul Toxicol Pharmacol. 2014 Aug;69(3):496-511
pubmed: 24874798
Development. 2014 Jul;141(13):2680-90
pubmed: 24903752
Congenit Anom (Kyoto). 2015 Feb;55(1):1-16
pubmed: 25109898
Mol Pharm. 2014 Oct 6;11(10):3642-55
pubmed: 25166282
Environ Health Toxicol. 2014 Dec 10;29:e2014021
pubmed: 25518841
Int J Mol Sci. 2014 Dec 30;16(1):660-76
pubmed: 25561223
Theranostics. 2015 Mar 01;5(6):631-42
pubmed: 25825602
J Nanosci Nanotechnol. 2015 Mar;15(3):2140-7
pubmed: 26413632
Int J Mol Sci. 2015 Dec 10;16(12):29398-416
pubmed: 26690408
ACS Nano. 2016 Mar 22;10(3):3042-68
pubmed: 26918485
Int J Mol Sci. 2016 Apr 16;17(4):576
pubmed: 27092499
Front Physiol. 2016 Apr 13;7:130
pubmed: 27148069
Arch Toxicol. 2016 Oct;90(10):2297-314
pubmed: 27342244
ACS Nano. 2016 Sep 27;10(9):8325-45
pubmed: 27419663
Aquat Toxicol. 2016 Nov;180:56-70
pubmed: 27658222
Yakugaku Zasshi. 2017;137(1):73-78
pubmed: 28049898
Int J Mol Sci. 2017 Mar 09;18(3):
pubmed: 28282918
Int J Occup Med Environ Health. 2017 Mar 30;30(2):213-229
pubmed: 28366952
Part Fibre Toxicol. 2017 Aug 23;14(1):31
pubmed: 28835236
Dev Cell. 2017 Sep 25;42(6):567-583
pubmed: 28950100
Part Fibre Toxicol. 2017 Nov 25;14(1):47
pubmed: 29178961
Toxicol Ind Health. 2018 Mar;34(3):169-177
pubmed: 29226784
Int J Mol Sci. 2017 Dec 13;18(12):null
pubmed: 29236059
J Biochem Mol Toxicol. 2018 Jan;32(1):null
pubmed: 29283201
ACS Appl Mater Interfaces. 2018 Apr 18;10(15):12518-12525
pubmed: 29561590
Front Pharmacol. 2018 Mar 20;9:253
pubmed: 29615914
Acta Pharm Sin B. 2018 Mar;8(2):165-177
pubmed: 29719777
Part Fibre Toxicol. 2018 Jul 16;15(1):31
pubmed: 30012173